The disclosure in the 'Purpose of Transaction' section of the filing uses pretty standard language. The firm said they reserve the right to formulate other plans and/or make other proposals, and take such actions with respect to their investment in the Issuer, including any or all of the actions set forth in paragraphs (a) through (j) of Item 4 of Schedule 13D, or acquire additional Common Stock or dispose of all the Common Stock beneficially owned by them, in the public market or privately negotiated transactions.
Warner Chilcott: ValueAct Capital Discloses 5.5% Stake
Feb 25 2007, 05:59 | about: WCRX
In a 13D filing after the close on Warner Chilcott Limited (WCRX), ValueAct Capital disclosed a 5.5% stake (13.8 million shares) in the company.